|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002092,
umls-concept:C0017387,
umls-concept:C0032385,
umls-concept:C0032659,
umls-concept:C0036497,
umls-concept:C0037296,
umls-concept:C0205164,
umls-concept:C0220825,
umls-concept:C0243072,
umls-concept:C0330312,
umls-concept:C0486805,
umls-concept:C1274040,
umls-concept:C1301820,
umls-concept:C1710263,
umls-concept:C1720722,
umls-concept:C1824952
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-12-22
|
|
pubmed:abstractText |
More than 95% of birch pollen-allergic subjects react with the major birch pollen allergen, Bet v 1, and almost 60% of them are sensitized exclusively to this allergen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Allergens,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Plant,
http://linkedlifedata.com/resource/pubmed/chemical/Bet v 1 allergen, Betula,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin E,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0091-6749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
969-77
|
|
pubmed:dateRevised |
2011-6-21
|
|
pubmed:meshHeading |
pubmed-meshheading:10550741-Adolescent,
pubmed-meshheading:10550741-Adult,
pubmed-meshheading:10550741-Allergens,
pubmed-meshheading:10550741-Antigens, Plant,
pubmed-meshheading:10550741-Asthma,
pubmed-meshheading:10550741-Conjunctivitis, Allergic,
pubmed-meshheading:10550741-Evaluation Studies as Topic,
pubmed-meshheading:10550741-Female,
pubmed-meshheading:10550741-Genetic Engineering,
pubmed-meshheading:10550741-Humans,
pubmed-meshheading:10550741-Immunoglobulin E,
pubmed-meshheading:10550741-Immunoglobulin G,
pubmed-meshheading:10550741-Immunoglobulins,
pubmed-meshheading:10550741-Intradermal Tests,
pubmed-meshheading:10550741-Male,
pubmed-meshheading:10550741-Middle Aged,
pubmed-meshheading:10550741-Peptide Fragments,
pubmed-meshheading:10550741-Plant Proteins,
pubmed-meshheading:10550741-Pollen,
pubmed-meshheading:10550741-Recombinant Fusion Proteins,
pubmed-meshheading:10550741-Seasons,
pubmed-meshheading:10550741-Skin Tests,
pubmed-meshheading:10550741-Sweden,
pubmed-meshheading:10550741-Trees
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
|
|
pubmed:affiliation |
Department of Clinical Immunology, Karolinska Hospital, Stockholm, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
